Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | BPH Global Subsidiary to Investigate Commercial Extraction of Critical Minerals from Seaweed | 1 | smallcaps.com.au | ||
Do | BPH GLOBAL LTD: BPH Global to Advance Rare Earth Element Recovery Research | - | ASX | ||
Mi | BPH GLOBAL LTD: Notification of cessation of securities - BP8 | 1 | ASX | ||
Mo | BPH GLOBAL LTD: Preliminary Final Report Additional Information | - | ASX | ||
29.08. | BPH GLOBAL LTD: Preliminary Final Report | - | ASX | ||
BPH GLOBAL Aktie jetzt für 0€ handeln | |||||
21.08. | BPH GLOBAL LTD: Strong Seaweed Sales Results 50.9% Increase on Prior Period | - | ASX | ||
13.08. | BPH GLOBAL LTD: Trade Financing Facility to Accelerate Seaweed Operations | - | ASX | ||
11.08. | BPH GLOBAL LTD: TPIH To Conduct Additional Assays On Seaweed Species | - | ASX | ||
31.07. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
30.07. | BPH GLOBAL LTD: Final Assay Results Confirm Seaweed Metal Uptake Potential | - | ASX | ||
17.07. | BPH Global Ltd Reports Strong Second Month Revenue Growth for Seaweed Business | 1 | Finance News Network | ||
17.07. | BPH GLOBAL LTD: Second Month Seaweed Revenue Results Increase 17.7% | - | ASX | ||
15.07. | BPH Global Progresses Bioremediation Talks with Indonesian Authorities | 1 | Finance News Network | ||
15.07. | BPH GLOBAL LTD: Coastal Bioremediation Talks with Indonesian Authorities | - | ASX | ||
02.07. | BPH GLOBAL LTD: R&D Agreement for Development of seaweed-based bio-stimulant | - | ASX | ||
19.06. | BPH Global books $150,000 in first-month revenue from Indonesian seaweed venture | 1 | smallcaps.com.au | ||
19.06. | BPH GLOBAL LTD: Strong First Month Revenue Results From Seaweed Sales | - | ASX | ||
28.04. | XFRA USZ0: WIEDERAUFNAHME/RESUMPTION | 177 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
23.04. | XFRA USZ0: AUSSETZUNG/SUSPENSION | 100 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBPH GLOBAL LTD.... ► Artikel lesen | |
14.04. | BPH Global pens offtake agreement with China-based manufacturer | 2 | The Market Herald Australia |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PAION | 0,015 | -39,20 % | Paion Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
EPIGENOMICS | 0,870 | 0,00 % | PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq | ||
SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
NUREXONE BIOLOGIC | 0,500 | -1,96 % | NurExone Biologic: Im Rampenlicht der Fachpresse! | ||
REPLENISH NUTRIENTS | 0,042 | 0,00 % | ESGFIRE commends Replenish Nutrients on new business updates | ||
NEOVACS | 0,541 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.07.2025 | The following instruments on XETRA do have their first trading 18.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.07.2025
Aktien
1 KYG7388C1033 Qunabox Group Ltd.
2... ► Artikel lesen | |
AYALA PHARMACEUTICALS | 0,226 | 0,00 % | OS Therapies übernimmt Immuntherapie-Vermögenswerte von Advaxis | ||
GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | ||
EQUATORIAL RESOURCES | 0,094 | +2,19 % | EQUATORIAL RESOURCES LIMITED: June 2025 Quarterly Report | ||
TRIVARX | - | - | TRIVARX LTD: 30 patients enrolled in innovative mental health trial | ||
RECCE PHARMACEUTICALS | 0,206 | -1,90 % | Recce Pharmaceuticals Ltd.: RECCE 327 Topical Gel erweist sich in Infektionsmodellen mit Ratten als hochwirksam und beschleunigt die Wundheilung bei Brandwunden | Wichtige Eckdaten:
- RECCE 327 Topical Gel (R327G) ist hochwirksam gegen die
Methicillin-resistenten Keime Staphylococcus aureus und Pseudomonas aeruginosa in infizierten... ► Artikel lesen | |
CRISM THERAPEUTICS | - | - | Crism Therapeutics gets clearance for UK phase 2 trial | ||
THERANEXUS | 2,450 | -2,00 % | THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025 | Lyon, France - 10 July 2024, 6.pm CET - Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, today published its cash position as of 30 June 2025.
On... ► Artikel lesen | |
PYC THERAPEUTICS | - | - | Hot Stocks: Critical Resources, PYC Therapeutics, VRX Silica, Vulcan Energy | ||
PATRYS | 0,002 | 0,00 % | PATRYS LIMITED: Appendix 4G and Corporate Governance Statement |